You Searched For "vaccine makers" and got 20 results
Sort By:
2 mins read
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…
Kelly Cloonan
1 min read
Danish monkeypox-vaccine maker surges 17% after global health emergency declared
Bavarian Nordic extended its two-day gain to 31% on the WHO news as the company's CEO pledged to pr…
Filip De Mott
3 mins read
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…
1 min read
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…
Zinya Salfiti
3 mins read
Vaccine makers are making over $1,000 per second and furiously holding on to their monopolies
The COVID-19 pandemic created over 40 new billionaires in the pharmaceutical sector in the last two…
1 min read
Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial
The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …
Phil Rosen
3 mins read
China is still racing to develop its own mRNA jabs. But they won't use foreign vaccines to fight COVID because of 'national pride,' says South Korea's top vaccine maker.
After three years of zero-COVID policy, Beijing abruptly rolled back the policy in December, which …
Huileng Tan
1 min read
Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report
Both SII and Bharat Biotech are involved in producing Covid-19 vaccine. Moreover, Cyfirma add…
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
1 min read
Moderna tanks 14% after COVID-19 vaccine maker cuts yearly sales outlook and misses 3rd-quarter expectations
Short-term supply constraints led Moderna to cut its 2022 revenue outlook to a range of $18 billion…
Carla Mozée
2 mins read
How vaccine-makers are combating variants
These are Business Insider's biggest healthcare stories for February 1.
Lydia Ramsey Pflanzer
2 mins read
Moderna stock plummeted on Biden's support of waiving vaccine patent protections, but that backing won't have a material impact on the company, Morgan Stanley says
"Any new manufacturing operation could take 6-9 months to scale," said Morgan Stanley about compani…
Carla Mozée
2 mins read
Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…
Matthew Fox
2 mins read
India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did
Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…
2 mins read
Marjorie Taylor Greene, who has boasted about being unvaccinated, owns stock in 3 major vaccine makers
Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & John…
Bill Bostock
3 mins read
Bharat Biotech to make antigen for first-ever anti-malaria vaccine
The first dose of the vaccine has reached more than 500,000 children since the pilots we…
2 mins read
Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world
"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…
Matthew Fox
3 mins read
India has its eyes and hopes pinned on Adar Poonawalla— the world’s biggest vaccine maker who will be speaking at the Global Trends Festival 2020
If developing a vaccine for COVID-19 virus is the most important thing, the 39-year old Adar Poonaw…
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
2 mins read
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…